Feiyan Lin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Redox biology and oxidative stress
- Circular RNAs in diseases
Papers in
-
- Dermatologic Treatments and Research 3
-
- S100 Proteins and Annexins 4
- Heme Oxygenase-1 and Carbon Monoxide 3
- Co-authors
- Cao Hongcui (12 shared papers)Jiong Yu (10 shared papers)Lei Jiang (8 shared papers)Lufeng Hu (15 shared papers)Qiaoling Pan (7 shared papers)Lanjuan Li (6 shared papers)Xiaowei Shi (6 shared papers)Jiaqi Zhu (5 shared papers)
- Journals
- Pharmacology (3 papers)Chemical Research in Toxicology (2 papers)Journal of Chromatography B (2 papers)Lipids in Health and Disease (2 papers)Journal of Cosmetic Dermatology (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Feiyan Lin
43 papers receiving 885 citations
Feiyan Lin's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 190
- Molecular Biology 451
- Hepatology 44
- Genetics 53
- Pulmonary and Respiratory Medicine 108
Countries citing papers authored by Feiyan Lin
This map shows the geographic impact of Feiyan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiyan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiyan Lin more than expected).
Fields of papers citing papers by Feiyan Lin
This network shows the impact of papers produced by Feiyan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiyan Lin. The network helps show where Feiyan Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Feiyan Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury Hit paper breakdown → | 2022 | 159 |
| 2 | 2021 | 71 | |
| 3 | 2022 | 61 | |
| 4 | 2017 | 47 | |
| 5 | 2021 | 45 | |
| 6 | 2017 | 44 | |
| 7 | 2015 | 40 | |
| 8 | 2019 | 37 | |
| 9 | 2024 | 33 | |
| 10 | 2013 | 31 | |
| 11 | 2020 | 29 | |
| 12 | 2021 | 29 | |
| 13 | 2014 | 28 | |
| 14 | 2016 | 26 | |
| 15 | 2018 | 25 | |
| 16 | Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide. | 2014 | 23 |
| 17 | 2019 | 20 | |
| 18 | 2017 | 18 | |
| 19 | 2019 | 13 | |
| 20 | 2022 | 11 |
About Feiyan Lin
Feiyan Lin is a scholar working on Dermatology, Molecular Biology, Hepatology, Complementary and alternative medicine and Cancer Research, having authored 44 papers that have together received 894 indexed citations. Recurring topics across this work include Paraquat toxicity studies and treatments (6 papers), Traditional Chinese Medicine Analysis (4 papers), S100 Proteins and Annexins (4 papers), Dermatologic Treatments and Research (3 papers), Liver Disease and Transplantation (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers), Biomarkers in Disease Mechanisms (2 papers) and Sperm and Testicular Function (2 papers). The work is most often cited by research in Cancer Research (190 citations), Molecular Biology (451 citations), Hepatology (44 citations), Genetics (53 citations) and Pulmonary and Respiratory Medicine (108 citations). Feiyan Lin has collaborated with scholars based in China and United States. Frequent co-authors include Cao Hongcui, Jiong Yu, Lei Jiang, Lufeng Hu, Qiaoling Pan, Lanjuan Li, Xiaowei Shi, Jiaqi Zhu, Bing Feng and Jiahang Zhou. Their work appears in journals such as Pharmacology, Chemical Research in Toxicology, Journal of Chromatography B, Lipids in Health and Disease and Journal of Cosmetic Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.